The Patent Finder
US

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

US 12,331,048 In force
OverviewFamilyAssignmentsSources & methods

Term ends Mar 24, 2043 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Mar 27, 2023 as application 18/190,920 · Granted Jun 17, 2025
Base term, 20 years from filing
Today
20 years from filing
2023 2043
Clock starts
Mar 24, 2023
Term ends
Mar 24, 2043
Granted
Jun 17, 2025
base term Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 24, 2023, when the earliest non-provisional application in its chain was filed (this one was filed Mar 27, 2023); a parent in its chain could not be resolved (the next row)Mar 24, 2043High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 24, 2043Medium confidence

This family

US 11,618,751In force
Mar 2042
Mar 2042
US 12,168,657In force
Mar 2042
Mar 2042
Application PCT/US2023/064967PCT application
no patent term
no patent term
US 12,331,048this patent
Mar 2043
Mar 2043
US 12,195,460In force
Mar 2042
Mar 2042
US 12,312,351In force
Mar 2042
Mar 2042
US 12,398,136In force
Mar 2043
Mar 2043
Application 18/799,636Pending
not computed
not computed
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 16, 2023
Reel 65587, frame 843
Dorich, Stéphane; Chefson, Amandine; Ciblat, StéphaneVentus Therapeutics, Inc.Assignment of Assignor's Interest
Nov 16, 2023
Reel 65587, frame 909
Ventus Therapeutics, Inc.Ventus Therapeutics U.S., Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited